Professional Seasonal Analysis for Trading

Inovio Pharmaceuticals, Inc. - Common Stock (INO)

Seasonality Analysis

Stocks 27 Years Analyzed

Inovio Pharmaceuticals, Inc. - Common Stock Annual Seasonality Statistics

10.88%
Avg Annual Return
41.1%
Avg Monthly Win Rate
6/12
Positive Months
27
Years Analyzed

Inovio Pharmaceuticals, Inc. - Common Stock Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January BEST 10.25%
59%
Moderate
February 0.67%
37%
Weak
March -1.04%
33%
Very Weak
April -0.54%
33%
Very Weak
May -1.71%
46%
Weak
June 6.43%
42%
Weak
July 2.89%
38%
Weak
August -1.06%
46%
Weak
September WORST -8.02%
38%
Very Weak
October 1.65%
42%
Weak
November -0.23%
38%
Very Weak
December 1.60%
38%
Weak

Inovio Pharmaceuticals, Inc. - Common Stock 2026 vs Historical Pattern

Current Position
16.67
Historical Avg Position
45.72
Deviation
-29.05
Performance
Significantly Below Average

Inovio Pharmaceuticals, Inc. - Common Stock Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for INO with overlay patterns, custom date ranges, and more.

Create Free Account

Inovio Pharmaceuticals, Inc. - Common Stock Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Inovio Pharmaceuticals, Inc. - Common Stock Seasonal Historical Performance

Historical Performance

See historical average returns for INO across multiple timeframes.

Create Free Account

About Inovio Pharmaceuticals, Inc. - Common Stock (INO) Seasonality

Inovio Pharmaceuticals, Inc. - Common Stock (INO) has been analyzed using 27 years of historical data to identify seasonal patterns. Classified under Stocks, Inovio Pharmaceuticals, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.

The strongest month for Inovio Pharmaceuticals, Inc. - Common Stock is historically January, with an average return of 10.25% and a win rate of 59%. Conversely, September tends to be the weakest month, averaging -8.02% return.

Looking at the full calendar year, Inovio Pharmaceuticals, Inc. - Common Stock has an average annual return of 10.88% with an overall monthly win rate of 41.1%. Out of 12 months, 6 typically show positive average returns.

The seasonal pattern for Inovio Pharmaceuticals, Inc. - Common Stock has a consistency score of 41.2 (Poor), based on 27 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Inovio Pharmaceuticals, Inc. - Common Stock Seasonality FAQ

What is the best month to buy Inovio Pharmaceuticals, Inc. - Common Stock (INO)?

Historically, January has been the best month for Inovio Pharmaceuticals, Inc. - Common Stock, with an average return of 10.25% and a win rate of 59%. However, past performance does not guarantee future results.

What is the worst month for Inovio Pharmaceuticals, Inc. - Common Stock (INO)?

Based on historical data, September has been the weakest month for Inovio Pharmaceuticals, Inc. - Common Stock, with an average return of -8.02%. This is a historical observation and does not guarantee future results.

How reliable is INO seasonality data?

The seasonality analysis for Inovio Pharmaceuticals, Inc. - Common Stock is based on 27 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Inovio Pharmaceuticals, Inc. - Common Stock seasonality in my trading?

Use Inovio Pharmaceuticals, Inc. - Common Stock (INO) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.